Skip to main content
vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
38.16
-1.16 (-2.95%)
At close: Feb 27, 2026, 4:00 PM EST
38.25
+0.09 (0.24%)
After-hours: Feb 27, 2026, 4:10 PM EST

vTv Therapeutics Revenue

vTv Therapeutics had revenue of $17.00K in the twelve months ending September 30, 2025, down -98.30% year-over-year. In the year 2024, vTv Therapeutics had annual revenue of $1.02M.

Revenue (ttm)
$17.00K
Revenue Growth
-98.30%
P/S Ratio
27,854.29
Revenue / Employee
$739
Employees
23
Market Cap
473.52M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.02M--
Dec 31, 2023---
Dec 31, 20222.02M-1.99M-49.61%
Dec 31, 20214.01M-2.41M-37.56%
Dec 31, 20206.41M3.65M132.05%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Autolus Therapeutics 51.13M
Invivyd 50.04M
Lineage Cell Therapeutics 10.82M
4D Molecular Therapeutics 120.00K
Lyell Immunopharma 41.00K
Revenue Rankings

VTVT News

More News